Jiřı́ Mayer

28.5k citations
422 papers · 8.8k · 3 hit papers · h-index 42

Impact in

  • Genetics top 0.05%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematology top 0.1%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
    • Platelet Disorders and Treatments

Papers in

    • Chronic Lymphocytic Leukemia Research 154
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 30
    • Chronic Myeloid Leukemia Treatments 81
    • Acute Myeloid Leukemia Research 48
    • Hematopoietic Stem Cell Transplantation 27

Jiřı́ Mayer

398 papers receiving 8.7k citations

Jiřı́ Mayer's Hit Papers

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials 2018 · 243 citations
2430+5+10Years since publication2505007501000

Peers

Jiřı́ Mayer
Comparison fields: 5 of 138
  • Genetics 4.2k
  • Hematology 3.8k
  • Pathology and Forensic Medicine 2.2k
  • Rheumatology 1.0k
  • Oncology 1.4k
Replace Andrew Grigg with:
Andrew Grigg Australia
Steven Coutré United States
Peter Vandenberghe Belgium
Hagop Kantarjian United States
Bruno Varet France
Attilio Orazi United States
Gregor Verhoef Belgium
Robert P. Hasserjian United States
Charles Koller United States
Rüdiger Hehlmann Germany
Jiřı́ Mayer relative to Andrew Grigg Australia Andrew Grigg's profile →
Citations per field
00.5×1.6×
Andrew Grigg · 1×
Citations per year

Countries citing papers authored by Jiřı́ Mayer

Since Specialization
Citations

This map shows the geographic impact of Jiřı́ Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiřı́ Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiřı́ Mayer more than expected).

Fields of papers citing papers by Jiřı́ Mayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiřı́ Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiřı́ Mayer. The network helps show where Jiřı́ Mayer may publish in the future.

Co-authors

The 25 scholars most cited alongside Jiřı́ Mayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jiřı́ Mayer Line = papers co-authored together Jiřı́ Mayer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 422 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Hit paper breakdown →
20101108
2
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
Hit paper breakdown →
2016631
3 2010414
4 2007409
5
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
Hit paper breakdown →
2018243
6 2016233
7 2017224
8 2009177
9 2018154
10 2009132
11 2006129
12 2011117
13 2014107
14 2018101
15 201096
16 201186
17 200986
18 201683
19 201183
20 201982

About Jiřı́ Mayer

Jiřı́ Mayer is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 422 papers that have together received 8.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (154 papers), Lymphoma Diagnosis and Treatment (100 papers), Chronic Myeloid Leukemia Treatments (81 papers), Acute Myeloid Leukemia Research (48 papers), Acute Lymphoblastic Leukemia research (39 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (30 papers), Immunodeficiency and Autoimmune Disorders (30 papers) and Hematopoietic Stem Cell Transplantation (27 papers). The work is most often cited by research in Genetics (4.2k citations), Hematology (3.8k citations), Pathology and Forensic Medicine (2.2k citations), Rheumatology (1.0k citations) and Oncology (1.4k citations). Jiřı́ Mayer has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Šárka Pospı́šilová, Michael Doubek, Andreas Hochhaus, Michele Baccarani, Hagop M. Kantarjian, Jörge E. Cortes, Charles Chuah, Concepción Boqué, Neil P. Shah and Marek Mráz. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Hematology, American Journal of Hematology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact